NuCana PLC (NCNA)
4.00
0.00 (0.00%)
USD |
NASDAQ |
Apr 29, 16:00
4.00
0.00 (0.00%)
Pre-Market: 08:36
NuCana Cash from Operations (TTM): -32.90M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -32.90M |
September 30, 2023 | -42.79M |
June 30, 2023 | -26.73M |
March 31, 2023 | -29.67M |
December 31, 2022 | -28.68M |
September 30, 2022 | -33.11M |
June 30, 2022 | -36.91M |
March 31, 2022 | -33.21M |
December 31, 2021 | -32.78M |
September 30, 2021 | -30.35M |
June 30, 2021 | -36.34M |
March 31, 2021 | -30.92M |
December 31, 2020 | -27.75M |
Date | Value |
---|---|
September 30, 2020 | -22.16M |
June 30, 2020 | -24.96M |
March 31, 2020 | -30.45M |
December 31, 2019 | -30.43M |
September 30, 2019 | -28.04M |
June 30, 2019 | -23.22M |
March 31, 2019 | -20.41M |
December 31, 2018 | -16.31M |
September 30, 2018 | -16.89M |
June 30, 2018 | -14.69M |
March 31, 2018 | -13.25M |
December 31, 2017 | -11.24M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-42.79M
Minimum
Sep 2023
-22.16M
Maximum
Sep 2020
-30.60M
Average
-30.43M
Median
Dec 2019
Cash from Operations (TTM) Benchmarks
Adaptimmune Therapeutics PLC | -140.88M |
Biodexa Pharmaceuticals Plc | -8.515M |
Autolus Therapeutics PLC | -145.59M |
Mereo BioPharma Group PLC | -21.13M |
Bicycle Therapeutics PLC | -60.63M |